Frisch Financial Group, Inc. Illumina, Inc. Transaction History

Frisch Financial Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$347.28 - $421.83 $275,740 - $334,933	-794 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$405.61 - $524.84 $322,054 - $416,722	794 New	794 $322,000
Q3 2021 Nov 10, 2021	SELL	$405.61 - $524.84 $322,054 - $416,722	-794 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$372.84 - $481.5 $61,518 - $79,447	-165 Reduced 17.21%	794 $376,000
Q1 2021 May 13, 2021	BUY	$361.28 - $504.76 $18,064 - $25,238	50 Added 5.5%	959 $368,000
Q4 2020 Jan 26, 2021	BUY	$292.7 - $370.96 $11,708 - $14,838	40 Added 4.6%	909 $336,000
Q3 2020 Nov 10, 2020	BUY	$268.51 - $400.74 $20,138 - $30,055	75 Added 9.45%	869 $269,000
Q2 2020 Aug 06, 2020	SELL	$256.46 - $373.01 $4,359 - $6,341	-17 Reduced 2.1%	794 $294,000
Q4 2019 Jan 28, 2020	SELL	$288.29 - $335.49 $14,414 - $16,774	-50 Reduced 5.81%	811 $269,000
Q2 2019 Aug 08, 2019	BUY	$300.59 - $368.15 $15,029 - $18,407	50 Added 6.17%	861 $317,000
Q4 2018 Feb 14, 2019	BUY	$272.46 - $366.54 $220,965 - $297,263	811 New	811 $243,000

904

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Frisch Financial Group, Inc. with notifications on news.